Skip to content
Clinical Trials – home
BulgariaBack to Bulgaria

Clinical trials in Stara Zagora – page 14

168 clinical trials in Stara Zagora, Bulgaria across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Stara Zagora at a glance
168
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

168 trials in Stara Zagora

Open in trial search

Open angle glaucoma

Not recruiting

Study on the Effectiveness of Bimatoprost SR for Patients with Open-Angle Glaucoma or Ocular Hypertension

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Bimatoprost
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Atrial fibrillation+2

Not recruiting

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Bayer AG

Hidradenitis

Not recruiting

Study on Upadacitinib for Adults and Adolescents with Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure

Investigational
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Crohn's disease

Not recruiting

Study of RVT-3101 for Treating Moderate to Severe Crohn's Disease in Patients

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:PF-06480605
  • Sponsor:F. Hoffmann-La Roche AG

Asthma

Not recruiting

Study on RPT193 for Adults with Moderate-to-Severe Asthma Partially Controlled by Inhaled Corticosteroids and Long-Acting Beta 2 Agonists

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:Rapt Therapeutics Inc.

Myelofibrosis

Not recruiting

Study on the Effectiveness and Safety of Selinexor and Ruxolitinib for Patients with Myelofibrosis Who Have Not Received Prior Treatment

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Aprepitant
  • Sponsor:Karyopharm Therapeutics Inc.

Hidradenitis

Not recruiting

Study on the Effectiveness and Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:4-[3-(Cyanomethyl)-3-(3',5'-Dimethyl-1H,1'H-[4,4'-Bipyrazol]-1-Yl)Azetidin-1-Yl]-2,5-Difluoro-N-[(2S)-1,1,1-Trifluoropropan-2-Yl]Benzamide
  • Sponsor:Incyte Corp.

Hidradenitis

Not recruiting

Study to Evaluate the Effectiveness of Spesolimab for Patients with Moderate to Severe Hidradenitis Suppurativa

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Spesolimab
  • Sponsor:Boehringer Ingelheim Espana S.A.

Colitis ulcerative

Not recruiting

Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

Study on Rifaximin for Delaying Hepatic Encephalopathy in Cirrhosis Patients

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Rifaximin
  • Sponsor:Salix Pharmaceuticals Inc.

Asthma

Not recruiting

Study on Reducing Asthma Medication with Tezepelumab in Patients Aged 12 to 80 with Severe Asthma

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Tezepelumab
  • Sponsor:AstraZeneca AB

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Stara Zagora

What the registry says about research in the country

01 Inflammatory Conditions

Clinical trials focusing on inflammatory disorders are evaluating novel treatments for conditions including psoriatic arthritis and hidradenitis suppurativa. Researchers are testing innovative therapies targeting specific inflammatory pathways.

  • Psoriatic Arthritis Studies
  • Hidradenitis Suppurativa Research
  • Chronic Rhinosinusitis Treatments

These studies aim to improve quality of life for patients with chronic inflammatory conditions.

02 Respiratory Medicine

Research in respiratory diseases includes multiple trials investigating new treatments for asthma. Studies are examining both established and experimental medications to enhance breathing function and disease control.

  • Asthma Management
  • Respiratory Function Studies
  • Airway Inflammation Research

Emphasis is placed on developing treatments for moderate to severe cases.

03 Oncology and Hematology

Groundbreaking research in blood cancers and solid tumors includes studies on acute myeloid leukemia, chronic lymphocytic leukemia, and prostate cancer. Novel therapeutic approaches are being evaluated.

  • Leukemia Treatments
  • Prostate Cancer Therapy
  • Blood Disorder Management

These trials aim to improve survival rates and treatment outcomes.

04 Neurological Conditions

Studies in neurological disorders are investigating treatments for epilepsy and examining extended-release formulations of existing medications to improve seizure control.

  • Epilepsy Management
  • Seizure Control Studies
  • Drug-Resistant Epilepsy Research

Focus is on developing more effective treatment options for patients with refractory conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.